Arvelle Therapeutics
Basel
About Arvelle Therapeutics
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $221.8M
- Funding stage: M&A
- Last round: Series A (May 2020)
- Website: arvelletx.com
- Phone: (888) 317-1041
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/arvelle-therapeutics-45773 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.